1. Home
  2. PLSE vs RBCAA Comparison

PLSE vs RBCAA Comparison

Compare PLSE & RBCAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • RBCAA
  • Stock Information
  • Founded
  • PLSE 2014
  • RBCAA 1974
  • Country
  • PLSE United States
  • RBCAA United States
  • Employees
  • PLSE N/A
  • RBCAA N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • RBCAA Major Banks
  • Sector
  • PLSE Health Care
  • RBCAA Finance
  • Exchange
  • PLSE Nasdaq
  • RBCAA Nasdaq
  • Market Cap
  • PLSE 1.3B
  • RBCAA 1.3B
  • IPO Year
  • PLSE 2016
  • RBCAA 1998
  • Fundamental
  • Price
  • PLSE $16.99
  • RBCAA $63.57
  • Analyst Decision
  • PLSE
  • RBCAA
  • Analyst Count
  • PLSE 0
  • RBCAA 0
  • Target Price
  • PLSE N/A
  • RBCAA N/A
  • AVG Volume (30 Days)
  • PLSE 154.6K
  • RBCAA 21.1K
  • Earning Date
  • PLSE 05-06-2025
  • RBCAA 04-24-2025
  • Dividend Yield
  • PLSE N/A
  • RBCAA 2.81%
  • EPS Growth
  • PLSE N/A
  • RBCAA 12.83
  • EPS
  • PLSE N/A
  • RBCAA 5.14
  • Revenue
  • PLSE N/A
  • RBCAA $330,428,000.00
  • Revenue This Year
  • PLSE N/A
  • RBCAA $1.56
  • Revenue Next Year
  • PLSE N/A
  • RBCAA $3.87
  • P/E Ratio
  • PLSE N/A
  • RBCAA $12.49
  • Revenue Growth
  • PLSE N/A
  • RBCAA 6.29
  • 52 Week Low
  • PLSE $6.60
  • RBCAA $46.55
  • 52 Week High
  • PLSE $25.00
  • RBCAA $80.68
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 36.10
  • RBCAA 36.86
  • Support Level
  • PLSE $16.48
  • RBCAA $64.76
  • Resistance Level
  • PLSE $17.91
  • RBCAA $66.83
  • Average True Range (ATR)
  • PLSE 1.22
  • RBCAA 1.73
  • MACD
  • PLSE -0.21
  • RBCAA -0.26
  • Stochastic Oscillator
  • PLSE 14.39
  • RBCAA 9.96

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through six reportable segments. It has traditional banking which generates the majority of revenue, warehouse, mortgage banking, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

Share on Social Networks: